Clarius adds AI features to handheld ultrasound scanners

May 15, 2021

Handheld-ultrasound technology developer Clarius Mobile Health has added artificial intelligence (AI) features to its handheld ultrasound scanners.

Version 8.0 of the Clarius ultrasound app, Clarius Auto Preset AI, automatically detects body anatomy when scanning. The update includes several new features, including the ability for clinicians to take and document photos that were acquired on mobile devices alongside ultrasound images.

Ideally suited for emergency medicine, EMS, critical care and primary care, these devices now enable clinicians to quickly examine the abdomen, heart, lungs, bladder, and other superficial structures without additional interaction through the Clarius App on their iOS or Android smart mobile devices. The system automatically provides a clear image depending on where the scanner is placed, automatically optimizing for depth, gain and other parameters.

Clarius Auto Preset AI makes ultrasound easier to use, even for novice users. While there are so many reasons to choose a wireless scanner, the Clarius Auto Present AI makes Clarius most useful for primary care and emergency medicine, especially in a sterile environment as physicians don’t need to touch any buttons or screens to examine an area of interest. They can simply place a fully disinfected/encased scanner on the torso and Clarius provides a clear window into the body.

The latest version is available with Clarius C3 HD multipurpose and Clarius PA HD phased-array ultrasound scanners.

Partagez ceci sur les réseaux sociaux

En savoir plus sur nous

PulseMedica is laser-focused on tackling vitreoretinal diseases

PulseMedica is laser-focused on tackling vitreoretinal diseases

The PulseMedica platform is a 3D image-guided therapy device that integrates powerful laser therapy, advanced medical imaging, and limitless machine learning (ML) for precision imaging and treatment of vitreoretinal disease. Vitreoretinal diseases exist within the clear gel (vitreous fluid) that fills the eye and retina at the back of the eye. PulseMedica’s device strives to automate the imaging and treatment process, enabling quick and precise disease targeting, thereby reducing the treatment time and reducing the risk of side effects and total time per patient, allowing for more patients to be treated each day.

Sonic Incytes is making liver screening more accessible 

Sonic Incytes is making liver screening more accessible 

Sonic Incytes, a Canadian artificial intelligence (AI)-assisted medical imaging company based out of Vancouver, British Columbia, is looking to change the way liver disease is screened and monitored globally. Their flagship, FDA cleared device, Velacur™, is revolutionizing the diagnosis and management of chronic liver disease. Their proprietary technology that grew into Velacur was originally developed by researchers at the University of British Columbia (UBC).